The treatment success rate for extensively drug-resistant tuberculosis (XDR-TB) in Brazil is expected to improve significantly from 81% in 2024 to 94% by 2028. This marks a substantial increase from the 2023 success rate of 78%. The year-on-year percentage growth accentuates a promising upward trend: 3.70% from 2024 to 2025, 3.57% from 2025 to 2026, 4.60% from 2026 to 2027, and 3.30% from 2027 to 2028. The compound annual growth rate (CAGR) over this five-year period is remarkable, illustrating an overall effective enhancement in treatment strategies.
Future trends to watch for:
- Continued improvements in diagnostic and treatment protocols influencing success rates.
- Potential impact of new drug introductions or resistance patterns on treatment outcomes.
- Public health initiatives and their long-term effects on TB management.
